home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Novel Continuous Activated Granulation

 
  September 21, 2016  
     
 
Xtalks Life Science Webinars, Online
2016-10-21


One of the most commonly used pharmaceutical manufacturing processes is granulation. Granulation is extensively used in the manufacturing of tablets or capsules which are most common ways in which therapeutic molecules are administered to patients. It is therefore not surprising that most efforts at developing continuous processes have been aimed at granulation.

This webinar will focus on the following topics:

 

  • Shortcomings associated with the current batch manufacturing processes
  • Advantages of continuous processing in general
  • Limitations observed in continuous processors today
  • Introduction to true continuous granulation technologies and the associated advantages
  • STEERLife’s proprietary Continuous Activated Granulation technologies – continuous wet granulation, moisture and shear activated dry granulation and melt granulation
  • Case studies.
 
 
Organized by: Xtalks Life Science Webinars
Invited Speakers: Dr. Babu Padmanabhan, Managing Director and Chief Knowledge Officer, STEERLife
Mr. Indu Bhushan, Chief Technical Officer, STEERLife
 
Deadline for Abstracts: 2016-10-21
 
Registration: https://attendee.gotowebinar.com/register/8238534351563001346
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.